Learn how we’re changing the world of medicine. Discover career opportunities, our product pipeline, and browse media resources. Meet Moderna.

Join Moderna as we pursue the uncharted reaches of possibility and make your mark on the future of medicine.

Meet Moderna Moderna’s goal is to explore the potential of messenger RNA (mRNA) science to help create a new generation of medicines for patients.

Moderna initiates first-in-human dosing for mRNA-1653, a combination vaccine with the potential to protect against more than one disease–human metapneumovirus (hMPV virus) and parainfluenza virus.

Find contact information, important phone numbers and addresses to Moderna head.

Noubar Afeyan, Ph.D. Co-founder and Chairman, Moderna; CEO, Flagship Pioneering Stéphane Bancel Chief Executive Officer Sandra Horning, M.D. Former Chief Medical Officer and Global Head of …

How can we help you? Report a side effect Online: Moderna's Adverse Event Intake Portal or U.S. HHS's Vaccine Adverse Event Reporting System

You should not get mNEXSPIKE if you had a severe allergic reaction after a previous dose of either mNEXSPIKE, SPIKEVAX (COVID-19 Vaccine, mRNA), or any Moderna COVID-19 vaccine or to any …

In addition to mRNA vaccines, Moderna is working on other applications of potential mRNA therapeutics that could help people with cancer, metabolic diseases and more.

Learn about Moderna's Spikevax® (COVID-19 Vaccine, mRNA) 2025-2026 Formula and how it helps protect against emerging variants, following ACIP recommendation.